Journal for ImmunoTherapy of Cancer (Nov 2020)

249 Targeting IFNβ-regulated secretory profiles to overcome acquired anti-PD-L1 resistance

Yuhao Shi,
Melissa Dolan,
Michalis Mastri,
Kevin Eng,
John Ebos

Affiliations

Yuhao Shi: Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
Melissa Dolan: Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
Michalis Mastri: Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
Kevin Eng: Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
John Ebos: Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

DOI: https://doi.org/10.1136/jitc-2020-SITC2020.0249
Journal volume & issue: Vol. 8, no. Suppl 3

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal